Renin-angiotensin system/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 14: | Line 14: | ||
==Subtopics== | ==Subtopics== | ||
<!-- List topics here that are included by this topic. --> | <!-- List topics here that are included by this topic. --> | ||
{{r|Angiotensin}} | {{r|Angiotensin}} | ||
{{r|Angiotensin receptor}} | {{r|Angiotensin receptor}} | ||
{{r|Peptidyl-dipeptidase A}} | |||
{{r|Renin}} | |||
==Other related topics== | ==Other related topics== | ||
| Line 25: | Line 25: | ||
{{r|Hypertension}} | {{r|Hypertension}} | ||
{{r|Kallikrein-kinin system}} | {{r|Kallikrein-kinin system}} | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Midodrine}} | |||
{{r|Compartment syndrome}} | |||
{{r|Opioid analgesic}} | |||
{{r|Human heart}} | |||
{{r|Renin}} | |||
Latest revision as of 07:01, 11 October 2024
- See also changes related to Renin-angiotensin system, or pages that link to Renin-angiotensin system or to this page or whose text contains "Renin-angiotensin system".
Parent topics
- Blood pressure [r]: Pressure of the blood on the arteries and other blood vessels. [e]
Subtopics
- Angiotensin [r]: Oligopeptides which are important in the regulation of blood pressure (vasoconstriction) and fluid homeostasis via the renin-angiotensin system. These include angiotensins derived naturally from precursor angiotensinogen, and those synthesized. [e]
- Angiotensin receptor [r]: Cell surface proteins that bind angiotensins and trigger intracellular changes influencing the behavior of cells. [e]
- Peptidyl-dipeptidase A [r]: Peptidyl-dipeptidase A is called Angiotensin I converting enzyme in the renin-angiotensin system and Kininase II in the kallikrein-kinin system. [e]
- Renin [r]: A highly specific (Leu-Leu) endopeptidase that generates angiotensin I from its precursor angiotensinogen, leading to a cascade of reactions which elevate blood pressure and increase sodium retention by the kidney in the renin-angiotensin system. [e]
- Angiotensin II receptor antagonist [r]: Agents that antagonize angiotensin II type 1 receptor. Included are angiotensin II analogs such as saralasin and biphenylimidazoles such as losartan. Some are used as antihypertensive agents. [e]
- Angiotensin-converting enzyme inhibitor [r]: Drugs mainly used to treat hypertension and heart failure, by hemodynamic effect inhibiting the renin-angiotensin system. [e]
- Hypertension [r]: A multisystem disease whose hallmark is the elevation of blood pressure. [e]
- Kallikrein-kinin system [r]: System of metabolic interactions by products produced in the distal nephron of the kidney. [e]
- Midodrine [r]: An adrenergic alpha agonist used as a vasoconstrictor agent in the treatment of hypotension. [e]
- Compartment syndrome [r]: A condition which increased pressure within a limited space, usually an extremity compromises the blood circulation and function of tissue within that space. This can be caused by tight external constriction, trauma, extravasation of an intraosseous infusion, or extreme exertion [e]
- Opioid analgesic [r]: Synthetic narcotic that has opiate-like activities, which induces analgesia by mimicking endogenous opioids, at opioid receptors in the brain. [e]
- Human heart [r]: The hollow, muscular organ that maintains the circulation of the blood. [e]
- Renin [r]: A highly specific (Leu-Leu) endopeptidase that generates angiotensin I from its precursor angiotensinogen, leading to a cascade of reactions which elevate blood pressure and increase sodium retention by the kidney in the renin-angiotensin system. [e]